Literature DB >> 2470677

Serotype 8- and serocluster-specific surface-expressed antigens of Ureaplasma urealyticum.

D Thirkell1, A D Myles, W C Russell.   

Abstract

The polypeptides of all 14 serotypes of Ureaplasma urealyticum were analyzed by one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver staining. The electrophoretic patterns did not allow ready discrimination of individual serotypes or seroclusters. The analysis of the antigens of serotype 8 was reported previously (B. L. Precious, D. Thirkell, and W. C. Russell, J. Gen. Microbiol. 133:2659-2676, 1987). In this study, three of the surface-expressed membrane antigens of 16, 17, and 96 kilodaltons were further investigated, and monoclonal antibodies were raised against these three polypeptides. The major 96-kilodalton polypeptide was serotype 8 specific, and the 16-kilodalton polypeptide was present only in the larger serocluster. We describe monoclonal antibody probes that unequivocally differentiate serotype 8 from the other serotypes and that separate the two seroclusters of the organism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470677      PMCID: PMC313342          DOI: 10.1128/iai.57.6.1697-1701.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Problems associated with serotyping strains of Ureaplasma urealyticum.

Authors:  G W Stemke; J A Robertson
Journal:  Diagn Microbiol Infect Dis       Date:  1985-07       Impact factor: 2.803

2.  Adenovirus antigens: a model system in mice for subunit vaccination.

Authors:  V Mautner; H N Willcox
Journal:  J Gen Virol       Date:  1974-12       Impact factor: 3.891

3.  Isolation and characterization of monoclonal antibodies to structural and nonstructural herpesvirus saimiri proteins.

Authors:  R E Randall; C Newman; R W Honess
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

4.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

5.  Comparison of human and animal Ureaplasmas by one- and two-dimensional protein analysis on polyacrylamide slab gel.

Authors:  C Mouches; D Taylor-Robinson; L Stipkovits; J M Bove
Journal:  Ann Microbiol (Paris)       Date:  1981 Sep-Oct

6.  Expanded serotyping scheme for Ureaplasma urealyticum strains isolated from humans.

Authors:  J A Robertson; G W Stemke
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

7.  Effects of manganese on the growth and morphology of Ureaplasma urealyticum.

Authors:  J A Robertson; M H Chen
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

8.  Polypeptide phosphorylation in adenovirus-infected cells.

Authors:  W C Russell; G E Blair
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

9.  Monoclonal antibodies against adenovirus type 5: preparation and preliminary characterization.

Authors:  W C Russell; G Patel; B Precious; I Sharp; P S Gardner
Journal:  J Gen Virol       Date:  1981-10       Impact factor: 3.891

10.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

View more
  8 in total

1.  Characterization of the immunoglobulin A protease of Ureaplasma urealyticum.

Authors:  R K Spooner; W C Russell; D Thirkell
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Palmitoylated proteins in Ureaplasma urealyticum.

Authors:  D Thirkell; A D Myles; W C Russell
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

3.  Immunoblot analysis of anti-Ureaplasma urealyticum antibody in pregnant women and newborn infants.

Authors:  C K Cunningham; C A Bonville; J H Hagen; J L Belkowitz; R M Kawatu; A M Higgins; L B Weiner
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

4.  Variable antigens of Ureaplasma urealyticum containing both serovar-specific and serovar-cross-reactive epitopes.

Authors:  H L Watson; D K Blalock; G H Cassell
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

5.  Development of a monoclonal antibody to a Ureaplasma urealyticum serotype 9 antigen.

Authors:  A Naessens; X Cheng; S Lauwers; J A Robertson
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

6.  Screening of an antigen target for immunocontraceptives from cross-reactive antigens between human sperm and Ureaplasma urealyticum.

Authors:  Jianli Shi; Zhengmin Yang; Min Wang; Guoyan Cheng; Ding Li; Yifei Wang; Yuancong Zhou; Xiaolong Liu; Chen Xu
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

7.  Identification and characterization of serotype 4-specific antigens of Ureaplasma urealyticum by use of monoclonal antibodies.

Authors:  X Cheng; A Naessens; S Lauwers
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Identification of serotype 1-, 3-, and 6-specific antigens of Ureaplasma urealyticum by using monoclonal antibodies.

Authors:  X Cheng; A Naessens; S Lauwers
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.